Sumitomo Pharma Co., Ltd.
Notice regarding the recognition of retirement benefit trust return income (special profit) in our standalone financial statements (Japanese standards)
Decision to fully return retirement benefit trust; return date is September 28, 2026; expected return amount about 26.1 billion yen. In the standalone financial statements, retirement benefit trust return income of about 17.3 billion yen is planned to be recognized as a special profit (there is no impact on the consolidated IFRS-compliant figures).
Key Figures
- Retirement benefit trust return expected amount: approx. 261 hundred million yen
- Retirement benefit trust return income: approx. 173 hundred million yen
- Scheduled return date: September 28, 2026
AI要約
Section heading
This release is an announcement regarding the full return of the retirement benefit trust and the recognition of related special profit. Since future benefit assets are expected to remain in excess, we have decided to return the retirement benefit trust and plan to recognize retirement benefit trust return income of about 17.3 billion yen as a special profit in the standalone financial statements (Japanese standards) for the fiscal year ending March 2027. There is no impact on the consolidated financial statements as they are IFRS-compliant.
Section 2 heading
With the return, we expect to amortize unrecognized actuarial differences in one lump sum, and the actual amount will be finalized at the time of return. Specific figures may be finalized at the time of future disclosure.
Sumitomo Pharma Co., Ltd.
Company overview · Stock price · Financial data · All IR
